These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19197461)

  • 41. Tumor-induced osteomalacia.
    Hewison M
    Curr Opin Rheumatol; 1994 May; 6(3):340-4. PubMed ID: 8060772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma.
    Ozcan Z; Erenel G; Aksoylar S; Kansoy S; Burak Z; Ozkiliç H
    Clin Nucl Med; 1999 Apr; 24(4):267-70. PubMed ID: 10466525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
    Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
    Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of non-small cell lung cancer viability and necrosis with three radiopharmaceuticals.
    Sobic-Saranovic D; Pavlovic S; Jovanovic D; Nebojsa K; Todorovic-Tirnanic M; Subotic D; Artiko V; Obradovic V
    Hell J Nucl Med; 2008; 11(1):16-20. PubMed ID: 18392221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability.
    Bhatnagar A; Vezza PR; Bryan JA; Atkins FB; Ziessman HA
    J Nucl Med; 1998 Sep; 39(9):1617-20. PubMed ID: 9744355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypophosphatemic osteomalacia demonstrated by Tc-99m MDP bone scan: a case report.
    Kim S; Park CH; Chung YS
    Clin Nucl Med; 2000 May; 25(5):337-40. PubMed ID: 10795690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-phase scintigraphy with technetium 99m-sestamibi in patients with hyperparathyroidism due to chronic renal failure.
    Muros MA; Bravo Soto J; López Ruiz JM; Rodríguez-Portillo M; Ramírez Navarro A; Bellón Guardia M; Perán F; Llamas-Elvira JM
    Am J Surg; 2007 Apr; 193(4):438-42. PubMed ID: 17368284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
    Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
    Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast tumor localization using sestamibi.
    Coover LR; Malaspina PJ
    Clin Nucl Med; 2002 Mar; 27(3):161-4. PubMed ID: 11852300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-induced osteomalacia: a case report.
    Romualdo-Silva DD; Silva BC; Caetano CV; Tibúrcio AM; Nunes MB; Chagas SA; Polito ET; Ferreira AR; Purisch S
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):378-82. PubMed ID: 19578602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumoral calcinosis demonstrated on Tc-99m sestamibi scintigraphy.
    Chang CY; Cheng CY; Shen DH; Bai CY; Lin LF; Huang WS
    Clin Nucl Med; 2008 Dec; 33(12):920-1. PubMed ID: 19033810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
    Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
    Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein.
    De Moerloose B; Van de Wiele C; Dhooge C; Philippé J; Speleman F; Benoit Y; Laureys G; Dierckx RA
    Eur J Nucl Med; 1999 Apr; 26(4):396-403. PubMed ID: 10199946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
    Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B
    Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Osteomalacia and giant cell tumor: a rare case].
    Sehli H; Daoud L; Ben Mbarek R; Ghorbel R; Ben Abdelghani K; Charfi H; Cheour I; Tarhouni L; Sellami S
    Tunis Med; 2008 Sep; 86(9):836-8. PubMed ID: 19472787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.
    Rhee Y; Lee JD; Shin KH; Lee HC; Huh KB; Lim SK
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):551-4. PubMed ID: 11318793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphaturic mesenchymal tumor.
    Siegel HJ; Rock MG; Inwards C; Sim FH
    Orthopedics; 2002 Nov; 25(11):1279-81. PubMed ID: 12452347
    [No Abstract]   [Full Text] [Related]  

  • 60. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.